LUNSUMIO

Concentrate for solution for infusion, 1mg
RxActive license

Active substance (INN)

mosunetuzumab

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength1mg
PackagingUkupno 1 bočica staklena sa 1ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerF. Hoffmann-La Roche AG, Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L01FX25)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateDecember 10, 2025

Analogs in Montenegro

1

Other medicines with the same active substance

LUNSUMIORx
Concentrate for solution for infusion, 30mgF. Hoffmann-La Roche AG
Source: CInMED register